- Report
- January 2020
- 40 Pages
United States
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Russia
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Japan
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Ireland
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Germany
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
France
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
China
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 40 Pages
Brazil
From €2499EUR$2,595USD£2,149GBP
- Report
- January 2020
- 80 Pages
Africa
From €3655EUR$3,795USD£3,143GBP
- Report
- March 2020
- 116 Pages
Global
From €4334EUR$4,500USD£3,727GBP
- Book
- January 2014
- 624 Pages
- Book
- March 2009
- 384 Pages
- Book
- April 2021
- 432 Pages
- Book
- January 2017
- 576 Pages
€1717EUR$1,910USD£1,528GBP
The Hypersensitivity market is a subset of the Allergy and Immunology market, focusing on the diagnosis and treatment of hypersensitivity reactions. Hypersensitivity reactions are caused by an overreaction of the immune system to a foreign substance, such as pollen, dust, or certain foods. Symptoms of hypersensitivity reactions can range from mild to severe, and can include skin rashes, asthma, and anaphylaxis. Treatment of hypersensitivity reactions typically involves the use of medications, such as antihistamines, corticosteroids, and immunosuppressants.
The Hypersensitivity market is a rapidly growing field, with new treatments and diagnostic tools being developed to improve patient outcomes. Companies in the Hypersensitivity market include Allergan, AstraZeneca, GlaxoSmithKline, Merck, Novartis, and Sanofi. Show Less Read more
